Previous studies have implicated the NF-κB signaling pathway in promoting tumor cell proliferation, while c-myc has been reported to correlate positively with IFITM3 expression in liver cancer cells though this relationship has not been established in AML. This evidence concerns the gene IFITM3 and liver cancer.